Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis C

Oncology (Switzerland)

Volumn 84, Issue , 2013, Pages 3-12

  Fujimoto, Kenji ^a   Kato, Michio ^a   Kudo, Masatoshi ^b   Yada, Norihisa ^b   Shiina, Tsuyoshi ^c   Ueshima, Kazuomi ^b   Yamada, Yukinori ^d   Ishida, Tetsushi ^d   Azuma, Masayoshi ^d   Yamasaki, Masaru ^d   Yamamoto, Keiji ^a   Hayashi, Norio ^e   Takehara, Tetsuo ^f  

^a Wakayama Medical Center   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Kaizuka City Hospital   (Japan)

^e KANSAI ROSAI HOSPITAL   (Japan)

^f OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis; Liver fibrosis; Real time tissue elastography; Ultrasound elastography

Indexed keywords

ALBUMIN; BILIRUBIN; CHOLESTEROL; CHOLINESTERASE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CHOLINESTERASE BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; ELASTOGRAPHY; FEMALE; GOLD STANDARD; HEPATITIS C; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTHROMBIN TIME; REAL TIME TISSUE ELASTOGRAPHY; THROMBOCYTE COUNT;

EID: 84874356267     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000345883     Document Type: Conference Paper

References (47)

1. WHO International Agency for Research on Cancer: World Cancer Report 2008. Section 1-global cancer control, chapter 1.3: worldwide cancer burden. http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index. php.
2. WHO International Agency for Research on Cancer: World Cancer Report 2008. Section 2-etiology of cancer, chapter 2.5: chronic Infections.
3. Yoshida H, Shiratori Y, Moriyama M, et al: Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med 1999; 131: 174-181.
4. Shiratori Y, Imazeki F, Moriyama M, et al: Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy. Ann Intern Med 2000; 132: 517-524.
5. Desmet VJ, Gerber M, Hoofnagle JH, et al: Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520.
6. Ichida F, Tsuji T, Omata M, et al: Classification report: new inuyama classification for histological assessment of chronic hepatitis. Internat Hepatol Comm 1996; 6: 112-119.
7. Ishak K, Baptista A, Bianchi L, et al: Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696.
8. Bataller R, Brenner DA: Liver fibrosis. J Clin Invest 2005; 115: 209-218.
9. Pinzani M, Rombouts K, Colagrande S: Fibrosis in chronic liver diseases: diagnosis and management. J Hepatol 2005; 42:S22-S26.
10. Dienstag JL: The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36: S152-S160.
11. Gebo KA, Herlong HF, Torbenson MS, et al: Role of liver biopsy in management of chronic hepatitis C: a systemic review. Hepatology 2002; 36: 161-172.
12. Regev A, Berho M, Jeffers LJ, Milikowski C, et al: Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-2618.
13. Bedossa P, Dargère D, Paradis V: Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 38: 1449-1457.
14. Omata M: A strategy of the treatment for the viral hepatitis (in Japanese). J Jpn Soc Int Med 2004; 93: 269-276.
15. Manning DS, Afdhai NH: Diagnosis and quantitation of fibrosis. Gastroenterology, 2008; 134: 1670-1681.
16. Wai CT, Greenson JK, Fontana RJ, et al: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 2003; 38: 518-526.
17. Imbert-Bismut F, Ratziu, Pieroni L, Charlotte F, et al: Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001; 357: 1069-1075.
18. Forns X, Ampurdanes S, Llovet JM, et al: Indentification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology 2001; 36: 986-992.
19. Freeman MP, Vick CW, Taylor KJ, et al: Regenerating nodules in cirrhosis: sonographic appearance with anatomic correlation. AJR Am J Roentgenol 1986; 146: 533-536.
20. Ishikawa H, Ono M, Goto M, et al: Ultrasonographic findings in patients with liver cirrhosis; relationships between parenchymal, superficial echo patterns, and histological findings (in Japanese). Jpn J Med Ultrason 1990; 17: 522-529.
21. Fujimoto K, Yamamoto Y, Waki H, et al: Tissue characterization using integrated backscatter in viral chronic liver disease. J Ultrasound Med 1999; 18(suppl):472.
22. Kumada T, Toyoda H, Ogawa S, et al: Quantification of fibrosis in hepatitis C using statistics analysis tool of ultrasonics (2nd report). Jpn J Med Ultrasonics 2007; 34:S641.
23. Ziol M, Handra-Luca A, Kettaneh A, et al: Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48-54.
24. Joo I, Choi BI: New Paradigm for management of hepatocellular carcinoma by imaging. Liver Cancer 2012; 1: 94-109.
25. Sandrin L, Fourquet B, Hasquenoph JM, et al: Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003; 29: 1705-1713.
26. Foucher J, Chanteloup E, Vergniol J, et al: Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-408.
27. Fraquelli M, Rigamonti C, Casazza G, et al: Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56: 968-973.
28. Kim DY, Kim SU, Park JY, Ahn SH, Song KJ, Han KH: FibroScan based risk estimation of HBV-related HCC occurrence: development and validation of a predictive model. Liver Cancer 2012; 1: 123.
29. Friedrich-Rust M, Wunder K, Kriener S, et al: Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 2009; 252: 595-604.
30. Shiina T, Nitta N, Ueno E, et al: Real time tissue elasticity imaging using the combined autocorrelation method. J Med Ultrasonics 1999; 26: 57-66.
31. Shiina T, Nitta N, Ueno E, et al: Real time tissue elasticity imaging using the combined autocorrelation method. J Med Ultrasonics 2002; 29: 119-128.
32. Joo I, Choi BI: New paradigm for management of hepatocellular carcinoma by imaging. Liver Cancer 2012; 1: 94-109.
33. Itoh A, Ueno E, Tohno E, et al: Breast disease: clinical application of US elastography for diagnosis. Radiology 2006; 239: 341-350.
34. Fukunari N: More accurate and sensitive diagnosis for thyroid tumors with elastography-detection and differential diagnosis of thyroid cancers. MEDIX Suppl. 2007. http://www.hitachi-medical.co.jp/tech/medix/pdf/supple/sup-05.pdf.
35. Tsutsumi M, Miyagawa T, Matsumura T, et al: Real-time balloon inflation elastography for prostate cancer detection and initial evaluation of clinic pathologic analysis, AJR Am J Roentgenol 2010; 194:W471-W476.
36. Hirooka Y, Itoh A, Kawashima H, et al: Diagnosis of pancreatic disorders using contrast-enhanced endoscopic ultrasonography and endoscopic elastography. Clin Gastroenterol Hepatol 2009; 7:S63-S67.
37. Fujimoto K, Wada S, Oshita M, et al: Noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis C using elastography. MEDIX Suppl. 2007. http://www.hitachi-medical.co.jp/tech/medix/pdf/supple/sup-07.pdf.
38. Tatsumi C, Kudo M, Ueshima K, et al: Noninvasive evaluation of hepatic fibrosis using serum fibrotic markers, transient elastography (FibroScan), and real-time tissue elastography. Intervirology 2008; 1:S27-S33.
39. Tatsumi C, Kudo M, Ueshima K, et al: Noninvasive evaluation of hepatic fibrosis for type C chronic hepatitis. Intervirology 2010; 53: 76-81.
40. Fujimoto K, Kato M, Tonomura A, et al: Non-invasive evaluation method of the liver fibrosis using real-time tissue elastography-usefulness of judgment liver fibrosis stage by Liver Fibrosis Index (LF Index) (in Japanese). Kanzo 2010; 51: 539-541.
41. Haralick RM, Shanmugan K, Dinstein I: Textural features for image classification. IEEE Trans Syst Man Cybern 1973; 3: 610-621.
42. Mittal D, Kumara V, et al: Neural network based focal liver lesion diagnosis using ultrasound images. Comp Med Imaging Graphics 2011; 35: 315-323.
43. Matsumura T, Shiina T, Oosaka T, et al: Development of real-time tissue elastography (in Japanese). MEDIX 2004; 41: 30-35.
44. Hoon L, Kim Y, Lee J: Regenerative nodules in liver cirrhosis: findings at CT during arterial portography and CT hepatic arteriography with histopathologic correlation. Radiology 1999; 210: 451-458.
45. Arena U, Vizzutti F, Abraldes JG, et al: Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C. Gut 2008; 57: 1288-1293.
46. Vispo E, Barreiro P, Del Valle J, et al: Overestimation of liver fibrosis staging using transient elastography in patients with chronic hepatitis C and significant liver inflammation. Antivir Ther 2009; 14: 187-193.
47. Rifai K, Cornberg J, Mederacke I, et al: Clinical feasibility of liver elastography by acoustic radiation force impulse imaging (ARFI). Dig Liver Dis 2011; 43: 491-497.